JTEC

JTEC EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of JTEC (3446.T) as of Oct 19, 2026 is 72.88 M JPY. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 113.82 M JPY — a change of -35.97% (lower).

EBITDA

72.88 MJPY

YoY

-35.97%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of JTEC is 2026 72.88 M JPY. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of JTEC was 2025 113.82 M JPY. It decreases by -35.97% lower compared to the previous year.

The JTEC EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2019
166.43 M JPY
Jan 1, 2020
34.01 M JPY
Jan 1, 2021
-244.47 M JPY
Jan 1, 2022
-71.22 M JPY
Jan 1, 2023
306.67 M JPY
Jan 1, 2024
285.84 M JPY
Jan 1, 2025
113.82 M JPY
Jan 1, 2026
72.88 M JPY
The JTEC EBITDA history
YEAREBITDAYoY
72.88 MJPY-35.97%
113.82 MJPY-60.18%
285.84 MJPY-6.79%
306.67 MJPY-530.59%
-71.22 MJPY-70.87%
-244.47 MJPY-818.76%
34.01 MJPY-79.56%
166.43 MJPY+96.49%
84.70 MJPY-34.91%
130.12 MJPY+71.14%
76.03 MJPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

JTEC Stock analysis

What does JTEC do? JTEC Corp, listed on the Tokyo Stock Exchange under ticker 3446.T with ISIN JP3386660009, is a Japanese company operating in the Health Care sector. Headquartered in Ibaraki-shi, Japan, the company employs 64 full-time staff. It completed its initial public offering on February 28, 2018. JTEC Corp develops, designs, manufactures, and sells automation systems, focusing on specialized equipment for scientific and medical applications. The company operates through two business segments. The Optical segment specializes in X-ray nano-collecting mirrors used in synchrotron radiation and X-ray free electron laser facilities, designed for advanced analytical applications in both basic research and industrial contexts. The Life Science and Equipment Development segment focuses on automatic cell culture devices and other automation equipment, serving medical, biotechnology, and research sectors. These devices are developed and sold for use in laboratories and research institutions. The company also provides outsourced manufacturing and proprietary products to research institutes and businesses across various industries. JTEC Corp's website is www.j-tec.co.jp, offering further information about its products and services. The company maintains a presence in the health care industry, leveraging automation technology to support scientific research and medical advancements. Its operations reflect a niche focus on precision engineering for specialized applications in high-tech research environments. JTEC is one of the most popular companies on Eulerpool.

Frequently Asked Questions about JTEC stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of JTEC is 72.88 M JPY in 2026.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of JTEC changed from 113.82 M JPY to 72.88 M JPY, representing a -35.97% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) JTEC since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s JTEC historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — JTEC

All Key Metrics — JTEC